Clinical outcomes by potency of P2Y12 inhibitor following COMBO DTS PCI: From the COMBO collaboration

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Jaya Chandrasekhar

Eastern Health, Melbourne (Australia)

8 More presentations in this session

Presentation thumbnail

Evolution of periprocedural modifications of oxidative stress and inflammation markers according to the length of implanted stent

Doctor C. Dumanschi (Chisinau, MD)

Presentation thumbnail

Association between tissue morphology of in-stent restenosis lesions assessed with optical coherence tomography and late-term results after percutaneous coronary intervention

Doctor T. Tada (Kurashiki, JP)

Presentation thumbnail

Evaluation of transradial versus transfemoral procedures in all-comers patients treated with the dual-therapy stent

Doctor D. Kalkman (Amsterdam, NL)

Abstract Slides

Presentation thumbnail

Impact of triglyceride deposit cardiomyovasculopathy, a novel type atherosclerosis with triglyceride deposition in coronary arteries, on neointimal proliferation after coronary stent-implantation

Doctor M. Suzuki (Aichi, JP)

Presentation thumbnail

COMBO stent PCI for elderly patients: one year clinical outcomes and DAPT cessation patterns from the global MASCOT registry

Doctor J. Chandrasekhar (Melbourne, AU)

Access the full session

Session thumbnail

Poster Session 2 - Coronary interventions: stents

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Percutaneous intervention is better than surgery in real life for most patients: pro

Congress Session

Complex PCI in practice: tips and tricks to take home

Congress Session

PCI complications: the lyrics from my worst nightmares

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources